Abstract Treatment of Takayasu's arteritis remains a demanding challenge to clinicians. In
many patients the course of the disease is characterized by frequent relapses and disease …

Takayasu arteritis (TA) is a rare large vessels vasculitis. Conventional therapy consists of
glucocorticoids which may be associated with other immunosuppressive drugs. However …

The objective of this study was to report the long-term use of tumor necrosis factor (TNF)
inhibitors in case series of patients with Takayasu's arteritis refractory to standard …

Objective To test the efficacy of Infliximab, a chimeric monoclonal antibody against TNF-α, in
the treatment of Takayasu arteritis. Materials and methods We used infliximab at an initial …

Takayasu's arteritis (TA) is a rare granulomatous vasculitic disease that affects the aorta and
its major branches. Recent studies have suggested that anti-TNFα biological therapies are …

We have experienced a Takayasu arteritis (TA) patient, successfully treated with infliximab,
who did not respond well to conventional therapy with glucocosteroid and methotrexate …

Takayasu arteritis (TA) is a chronic large vessel vasculitis affecting predominantly the aorta
45 and its main branches, as well as the pulmonary arteries (1, 2). Of unknown origin (3) …

Objective To report a single‐center experience with the use of tumor necrosis factor (TNF)
inhibitors in patients with Takayasu arteritis (TA). Methods We retrospectively studied a …

Objective: To assess the efficacy of anti-tumour necrosis factor (TNF) therapy to induce
remission in patients with Takayasu arteritis (TAK) refractory to other immunosuppressive …

Takayasu's arteritis is a granulomatous, large vessel vasculitis that affects the aorta, its major
branches and the pulmonary arteries. Compelling evidence exists to support the notion that …